High circulating CD39+ regulatory T cells predict poor survival for sepsis patients

International Journal of Infectious Diseases

Volumn 30, Issue , 2015, Pages e57-e63

  Huang, Huihuang ^a,b   Xu, Ruonan ^b   Lin, Fang ^b   Bao, Chunmei ^b   Wang, Siyu ^b   Ji, Chengcheng ^b   Li, Ke ^b   Jin, Lei ^b   Mu, Jingsong ^b   Wang, Yonggang ^b   Li, Lei ^b   Sun, Lijian ^b   Xu, Biao ^b   Zhang, Zheng ^b   Wang, Fu Sheng ^a,b  

^a MEDICAL SCHOOL OF CHINESE PLA   (China)

^b BEIJING 302 HOSPITAL   (China)

Author keywords

CD39; Prognosis; Regulatory t cell; Sepsis

Indexed keywords

CD39 ANTIGEN; APYRASE; LEUKOCYTE ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FLUORESCENCE; FOLLOW UP; HUMAN; MALE; OVERALL SURVIVAL; PHENOTYPE; RECEIVER OPERATING CHARACTERISTIC; REGULATORY T LYMPHOCYTE; SENSITIVITY AND SPECIFICITY; SEPSIS; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; AGED; IMMUNOLOGY; MIDDLE AGED; MORTALITY; SURVIVAL ANALYSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADULT; AGED; ANTIGENS, CD; APYRASE; FEMALE; HUMANS; MALE; MIDDLE AGED; SEPSIS; SURVIVAL ANALYSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; T-LYMPHOCYTES, REGULATORY;

EID: 84917707002     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2014.11.006     Document Type: Article

References (29)

1. Angus D.C., van der Poll T. Severe sepsis and septic shock. N Engl J Med 2013, 369:840-851.
2. Stearns-Kurosawa D.J., Osuchowski M.F., Valentine C., Kurosawa S., Remick D.G. The pathogenesis of sepsis. Annu Rev Pathol 2011, 6:19-48.
3. Levy M.M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31:1250-1256. SCCM/ESICM/ACCP/ATS/SI.
4. Balk R.A. Severe sepsis and septic shock. Crit Care Clin 2000, 16:179-192.
5. Angus D.C., Wax R.S. Epidemiology of sepsis: an update. Crit Care Med 2001, 29:S109-S116.
6. Chang K.C., Burnham C.A., Compton S.M., Rasche D.P., McDonough J.S., Korman A.J., et al. Blockade of the negative co-stimulatory molecules PD-1 and CTLA-4 improves survival in primary and secondary fungal sepsis. Crit Care 2013, 17:R85.
7. Hotchkiss R.S., Monneret G., Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 2013, 13:862-874.
8. Skrupky L.P., Kerby P.W., Hotchkiss R.S. Advances in the management of sepsis and the understanding of key immunologic defects. Anesthesiology 2011, 115:1349-1362.
9. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004, 22:531-562.
10. Singer B.D., King L.S., D'Alessio F.R. Regulatory T Cells as immunotherapy. Front Immunol 2014, 5:46.
11. + Treg immune regulation in the adult: from experiments to models. Front Immunol 2013, 4:378.
12. Deaglio S., Dwyer K.M., Gao W., Friedman D., Usheva A., Erat A., et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007, 204:1257-1265.
13. Nikolova M., Carriere M., Jenabian M.A., Limou S., Younas M., Kök A., et al. CD39/adenosine pathway is involved in AIDS progression. PLoS Pathog 2011, 7:e1002110.
14. Bastid J., Cottalorda-Regairaz A., Alberici G., Bonnefoy N., Eliaou J.F., Bensussan A. ENTPD1/CD39 is a promising therapeutic target in oncology. Oncogene 2013, 32:1743-1751.
15. Bone R.C., Balk R.A., Cerra F.B. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: The ACCP/SCCM Consensus Conference Committee.
16. +CD127(low) regulatory T cells. Arthritis Rheum 2013, 65:627-638.
17. + T reg cells. J Exp Med 2006, 203:1701-1711.
18. Hotchkiss R.S., Monneret G., Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 2013, 13:260-268.
19. Wang T.S., Deng J.C. Molecular and cellular aspects of sepsis-induced immunosuppression. J Mol Med 2008, 86:495-506.
20. Fu J., Xu D., Liu Z., Shi M., Zhao P., Fu B., et al. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 2007, 132:2328-2339.
21. Rezvani K., Mielke S., Ahmadzadeh M., Kilical Y., Savani B.N., Zeilah J., et al. High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood 2006, 108:1291-1297.
22. + regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis. J Immunol 2006, 177:7943-7949.
23. + T-regulatory-cells to immune suppression in sepsis. Shock 2007, 27:251-257.
24. Meisel C., Schefold J.C., Pschowski R., Baumann T., Hetzger K., Gregor J., et al. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med 2009, 180:640-648.
25. Huang H.H., Wang S.Y., Wang H.F., Fu J.L., Han P., Wang F.S. Phenotypical and functional characteristic of FoxP3(+);CD39(+); regulatory T cells in humans. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2010, 26:536-538.
26. + regulatory T cells are required for recovery from severe sepsis. PLoS One 2013, 8:e65109.
27. + Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 2007, 110:1225-1232.
28. +T regulatory cells correlates with progression of HBV infection. BMC Immunol 2012, 13:17.
29. Grant C.R., Liberal R., Holder B.S., Cardone J., Ma Y., Robson S.C., et al. Dysfunctional CD39POS regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis. Hepatology 2014, 59:1007-1015.